Symptomatic relief with flupentixol (Fluanxol) of the anxious-algetic-depressive syndrome complex in neurotic states. A double-blind, placebo-controlled study.
D000328:Adult; D000367:Age Factors; D000553:Ambulatory Care; D001007:Anxiety / Q000188:drug therapy; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy; D004361:Drug Tolerance; D000431:Ethanol / Q000008:administration & dosage / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009497:Neurotic Disorders / Q000188:drug therapy*; D010146:Pain / Q000188:drug therapy; D010879:Piperazines / Q000008:administration & dosage / Q000627:therapeutic use*; D010919:Placebos; D012737:Sex Factors; D013577:Syndrome; D014149:Tranquilizing Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D014966:Xanthenes / Q000008:administration & dosage / Q000627:therapeutic use*
D010879:Piperazines; D010919:Placebos; D014149:Tranquilizing Agents; D014966:Xanthenes; D000431:Ethanol